背景:患有炎症性肠病(IBD)的人经历了一系列侵袭性身体症状,包括腹痛,腹泻,和疲劳。这些急性症状消退并恢复,慢性症状和并发症经常持续。这种疾病的性质也可能导致个人经历心理困扰,包括焦虑和抑郁症状;然而,与IBD的身体症状不同,这些心理症状往往得不到治疗。
目的:本研究旨在评估可行性,可接受性,以及IBD成人虚拟正念减压(v-MBSR)的有效性。
方法:从艾伯塔省的诊所招募患有自我报告的焦虑或抑郁的IBD患者,加拿大将参加为期8周的v-MSBR干预。符合条件的患者使用视频会议平台参加了由精神科医生提供的v-MBSR。主要可行性结果包括试验吸收,坚持,出席,和流失率。次要有效性结果包括焦虑的测量,抑郁症,生活质量(QoL),和正念。在3个时间点收集有效性数据:基线,在干预完成时,完成后6个月。为了进一步评估可行性和可接受性,参与者在完成v-MBSR后被邀请参加半结构化访谈.
结果:64名(25%)转诊患者中共有16名(25%)同意参加v-MBSR,其中最常见的下降原因是缺乏时间,而16名(43.8%)参与者中的7名完成了该计划,并获得了令人鼓舞的效果,包括焦虑和抑郁症状减轻以及与健康相关的QoL增加,两者的改善在6个月随访时持续。参与者将改进的应对策略和疾病管理技术描述为v-MBSR的好处。
结论:IBD患者对精神科医生主导的虚拟焦虑管理干预感兴趣,但结果表明,对于某些IBD患者,v-MBSR可能过于耗时.完成干预的人可以接受v-MBSR,和改善焦虑,抑郁症,QoL是有希望和可持续的。未来的研究应尝试表征可能从v-MBSR等干预措施中受益最大的IBD患者。
BACKGROUND: Individuals with inflammatory bowel disease (IBD) experience cycles of aggressive physical symptoms including abdominal pain, diarrhea, and fatigue. These acute symptoms regress and return, and chronic symptoms and complications often linger. The nature of the disease can also cause individuals to experience psychological distress including symptoms of anxiety and depression; however, unlike the physical symptoms of IBD, these psychological symptoms often remain untreated.
OBJECTIVE: This
study aims to evaluate the feasibility, acceptability, and effectiveness of virtual mindfulness-based stress reduction (v-MBSR) for adults with IBD.
METHODS: IBD patients with self-reported anxiety or depression were recruited from clinics in Alberta, Canada to participate in an 8-week v-MSBR intervention. Eligible patients participated in v-MBSR delivered by
psychiatrists using a videoconferencing platform. Primary feasibility outcomes included
trial uptake, adherence, attendance, and attrition rates. Secondary effectiveness outcomes included measures of anxiety, depression, quality of life (QoL), and mindfulness. Effectiveness data were collected at 3 time points: baseline, at intervention completion, and 6 months after completion. To further assess feasibility and acceptability, participants were invited to participate in a semistructured interview after completing v-MBSR.
RESULTS: A total of 16 of the 64 (25%) referred patients agreed to participate in v-MBSR with the most common reason for decline being a lack of time while 7 of the 16 (43.8%) participants completed the program and experienced encouraging effects including decreased anxiety and depression symptoms and increased health-related QoL with both improvements persisting at 6-month follow-up. Participants described improved coping strategies and disease management techniques as benefits of v-MBSR.
CONCLUSIONS: Patients with IBD were interested in a psychiatrist-led virtual anxiety management intervention, but results demonstrate v-MBSR may be too time intensive for some patients with IBD patients. v-MBSR was acceptable to those who completed the intervention, and improvements to anxiety, depression, and QoL were promising and sustainable. Future studies should attempt to characterize the patients with IBD who may benefit most from interventions like v-MBSR.